Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PK +1.3% (guidance)
Other news:
- CHRS +16.4% (to divest ophthalmology franchise to Sandoz (SDZNY) in $170 mln upfront all cash dea)
- PHVS +15.4% (FDA lifting of the clinical hold of deucrictibant for the prophylactic treatment of HAE attacks)
- SGMT +8.5% (Topline Results from Phase 2b FASCINATE-2 Clinical Trial)
- AUTL +6.2% (acceptance of Biologics License Application for obecabtagene autoleucel)
- PROK +5.4% (files for $100 mln Open Market Sale Agreement relating to its Class A ordinary shares)
- SEDG +5% (announces 16% global workforce reduction)
- M +4.3% (Board of Directors Responds to Unsolicited Non-Binding Proposal from Arkhouse and Brigade; Arkhouse issues statement on Macy's)
- CELH +2.4% (announced its expansion into new international markets)
- IONS +2% (topline results from Phase 3 OASIS-HAE study)
- LDI +1.8% (provides supplemental information regarding the cybersecurity incident)
- ARWR +1.5% (Chief Medical Officer to depart)
- MANU +1.4% (names Omar Berrada as new CEO)
- SAVE +1.3% (JetBlue Airways and Spirit Airlines file notice of appeal)
- ATHE +1.1% (issues shareholder letter highlighting pipeline advances and key upcoming milestones)
- GNK +1% (Highlights Steps the Company Is Taking to Drive Sustainable, Long-Term Shareholder Value)
- PHI +1% (confirms the statement of the Chairman that PLDT is eyeing a lower capex number for 2024)
- SONY +0.9% (unit ends merger plans with Zee Entertainment Enterprises)
Analyst comments:
- S +7.3% (upgraded to Buy from Neutral at BTIG Research)
- FSLY +4.7% (upgraded to Neutral from Sell at Citigroup)
- PAGS +3.4% (upgraded to Neutral from Sell at Goldman)
- STNE +3.1% (upgraded to Buy from Neutral at Goldman)
- SHLS +2.4% (upgraded to Equal Weight from Underweight at Barclays)
- IFF +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- NSC +1% (upgraded to Outperform from Mkt Perform at Bernstein)
- UNP +0.9% (upgraded to Outperform from Mkt Perform at Bernstein)